Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.60    -0.20 (-0.08%)
Bid:
254.00
Ask:
254.80
Spread: 0.80 (0.315%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share re-purchase

17 Aug 2022 07:00

RNS Number : 2427W
Serco Group PLC
17 August 2022
 

Serco share repurchase programme

 

17 August 2022

 

Serco today provides this further announcement, in connection with its intention as announced on 23 February 2022 to repurchase shares valued at up to £90 million. As announced on 8 March 2022, the first buyback tranche was to repurchase shares with a value of up to £40 million during the period starting on 8 March 2022 and ending no later than 16 August 2022. This first buyback tranche has now completed and during that period the aggregate number of shares purchased was 25,245,738] shares. The second buyback tranche will be a programme with a value of up to £50 million (the "Programme"). This will occur during the period starting 17 August 2022 and ending no later than 31 December 2022 (the "Engagement Period"). The aggregate number of shares acquired by the Company shall not exceed the balance of 106,229,148 shares remaining of the 121,800,878 shares authorised by shareholders at the 2022 Annual General Meeting. It is intended that any shares repurchased under the Programme will be transferred into treasury and subsequently cancelled.

 

The Company has entered into an agreement with Barclays under which it has issued an irrevocable instruction to Barclays to manage the Programme for the Engagement Period. Barclays will carry out the instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase shares.

 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation) detailed information about the individual purchases can be seen below.

 

Ends

 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com

 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East. More information can be found at www.serco.com

 

LEI: 549300PT2CIHYN5GWJ21

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFFESMEESEFA
Date   Source Headline
17th Apr 20231:10 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20234:07 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20234:34 pmRNSDirector/PDMR Shareholding
12th Apr 20234:33 pmRNSDirector/PDMR Shareholding
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:34 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20231:20 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20231:46 pmRNSNotice of AGM - Replacement
20th Mar 20231:00 pmRNSNotice of AGM
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSTransaction in Own Shares
13th Mar 20237:00 amRNSTransaction in Own Shares
10th Mar 20237:00 amRNSTransaction in Own Shares
9th Mar 202311:47 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20231:00 pmRNSAnnual Financial Report
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 202310:00 amRNSTotal Voting Rights
28th Feb 202311:30 amRNSSerco share repurchase programme
28th Feb 20237:00 amRNS2022 Full Year Results
27th Feb 202310:00 amRNSHolding(s) in Company
23rd Feb 20237:00 amRNSSerco wins CMS rebid valued at $690m
22nd Feb 20239:13 amRNSFY2022 results revised date; guidance unchanged
3rd Jan 202312:15 pmRNSTotal Voting Rights
3rd Jan 202312:00 pmRNSDirectorate Change
15th Dec 20227:00 amRNSClosed period trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.